The Servier Golden Ticket Award is a competitive process aiming to foster, support and accelerate promising entrepreneurial innovation in Servier’s therapeutic areas of focus. The Golden Ticket winner will gain priority admission or renewal and a voucher for one year of incubator space. Winners also have access to Servier’s Research and Development mentorship.
Open call for applications: April 5, 2021
Due date for applications: April 30, 2021 at 11:59 PM EDT
Notification of finalist status: May 14, 2021
Finalists presentations: May 24-25, 2021
Notification of winners: June 1, 2021
Companies must also meet LabCentral’s / MBC BioLabs Golden Ticket criteria:
– Total equity funding raised must be less than $7.5M USD before the Golden Ticket is issued to them
– Companies must not have trailing 12-month revenues in excess of $3M USD
– Companies must be in the life sciences and have an impact on human health
– Companies must be financially and scientifically ready to move into LabCentral within two months of receiving the ticket
The decision to award any Golden Ticket, is solely within the judgment of Servier, and is not subject to any objection or appeal.